Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling PathwaysJonathan D. Urban(BioStrategies (United States)), Richard B. Mailman(Pennsylvania State University)NeuropsychopharmacologyMarch 22, 200610.1038/sj.npp.1301071Cited by 194SaveCiteExport RISWatch citationsRelated PapersSerum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP|PLoS ONE|2011|81Receptor Conformations Involved in Dopamine D2L Receptor Functional Selectivity Induced by Selected Transmembrane-5 Serine Mutations|Molecular Pharmacology|2012|32